Venture
Halda Therapeutics, LLC
Latest Form D 2024-08-12- CIK 1769401
- State CT
- Other Health Care
- 4 Form D offerings since 2019-03-01
- Total sold
- $198M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2019-03-01
- Latest round
- $126M
- 2024-08-12 · 021-521220
- Investors
- 20
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2024-08-12 · $126M
- 2019-03-01$6.3M021-333855
- 2021-12-10$41M021-424482
- 2024-05-24$24.2M021-514297
- 2024-08-12$126M021-521220
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($126M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-521220 | First filed2024-08-12 | Latest2024-08-12 | Sought$126M | Sold$126M | Investors20 | Exemptions506(b) |
| 021-514297 | First filed2024-05-24 | Latest2024-05-24 | Sought$36M | Sold$24.2M | Investors9 | Exemptions506(b) |
| 021-424482 | First filed2021-12-10 | Latest2021-12-10 | Sought$51M | Sold$41M | Investors11 | Exemptions506(b) |
| 021-333855 | First filed2019-03-01 | Latest2019-03-01 | Sought$25.2M | Sold$6.3M | Investors12 | Exemptions506(b) |
Who backs Halda Therapeutics, LLC — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-08-12
| Name | Relationship | Clarification |
|---|---|---|
| Scott Phillips | RelationshipExecutive Officer | Clarification— |
| Tim Shannon | RelationshipExecutive Officer, Director | ClarificationManager |
| Rebecca Frey | RelationshipDirector | ClarificationManager |
| Liam Ratcliffe | RelationshipDirector | ClarificationManager |
| Joe Cabral | RelationshipDirector | ClarificationManager |
| Nandita Shangari | RelationshipDirector | ClarificationManager |
| Arjun Goyal | RelationshipDirector | ClarificationManager |
| Rebecca Luse | RelationshipDirector | ClarificationManager |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Connecticut (CT)
- Exemptions
- Rule 506(b)
- First filed
- 2019-03-01
- Latest filing
- 2024-08-12
Who backs Halda Therapeutics, LLC
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗